IRadimed Corporation (IRMD) Earnings History
Elite Compounder14 years of earnings data (2012–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
IRadimed Corporation (IRMD) Earnings Overview
As of June 23, 2026, IRadimed Corporation (IRMD) reported trailing twelve-month net income of $24M, reflecting +16.7% year-over-year growth. The company earned $1.83 per diluted share over the past four quarters, with a net profit margin of 26.8%.
Looking at the long-term picture, IRMD's 5-year EPS compound annual growth rate (CAGR) stands at +73.9%, indicating exceptional earnings growth. The company achieved its highest annual net income of $22M in fiscal 2025, representing a new all-time high.
IRadimed Corporation maintains industry-leading profitability with a gross margin of 76.7%, operating margin of 31.2%, and net margin of 26.8%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including LNTH ($279M net income, 15.2% margin), PRCT (-$102M net income, -31.0% margin), ANGO (-$28M net income, -11.6% margin), IRMD has outperformed on profitability metrics. Compare IRMD vs LNTH →
IRMD Earnings vs Peers
Earnings metrics vs comparable public companies
IRMD Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22M | +16.9% | $26M | $1.75 | 26.8% | 31.2% |
| 2024 | $19M | +11.9% | $22M | $1.50 | 26.3% | 30.0% |
| 2023 | $17M | +34.0% | $20M | $1.35 | 26.2% | 30.6% |
| 2022 | $13M | +37.6% | $16M | $1.02 | 24.1% | 29.3% |
| 2021 | $9M | +581.2% | $10M | $0.74 | 22.3% | 23.5% |
| 2020 | $1M | -85.8% | $-756,091 | $0.11 | 4.3% | -2.4% |
| 2019 | $10M | +52.8% | $9M | $0.78 | 25.0% | 22.5% |
| 2018 | $6M | +1161.3% | $6M | $0.52 | 20.7% | 19.7% |
| 2017 | $499,764 | -93.1% | $1M | $0.04 | 2.2% | 5.6% |
| 2016 | $7M | -4.2% | $11M | $0.60 | 22.2% | 33.6% |
| 2015 | $8M | +267.2% | $12M | $0.60 | 23.8% | 36.4% |
| 2014 | $2M | +5.9% | $3M | $0.20 | 13.1% | 19.6% |
| 2013 | $2M | +100.5% | $3M | $0.19 | 17.1% | 24.6% |
| 2012 | $966,085 | - | $1M | $0.09 | 12.6% | 18.5% |
Download Data
Export IRMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IRMD — Frequently Asked Questions
Quick answers to the most common questions about buying IRMD stock.
What is IRMD earnings per share (EPS)?
IRMD trailing twelve-month (TTM) diluted EPS is $1.83, reflecting +16.7% year-over-year growth. The 5-year EPS CAGR is +73.9%. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is IRadimed Corporation's net income?
IRadimed Corporation (IRMD) trailing twelve-month net income is $24M as of 2025. Earnings grew +16.7% year-over-year. IRadimed Corporation has been profitable for 14 consecutive years.
Is IRMD profitable?
Yes, IRMD is profitable with a TTM net income of $24M and a net profit margin of +26.8%. IRadimed Corporation has generated profits for 14 consecutive years.
What is IRMD's earnings growth rate?
IRMD compound annual EPS growth rates (CAGR): 1-Year: +16.7%, 3-Year: +19.7%, 5-Year: +73.9%, 10-Year: +11.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are IRMD's profit margins?
IRadimed Corporation net profit margin is +26.8%, operating margin is +31.2%, and gross margin is +76.7%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +24.8%.
Is IRMD growing earnings?
Yes, IRMD earnings are accelerating — EPS growth of +16.7% exceeds the 5-year CAGR of +73.9%. TTM net income reached $24M. Earnings momentum is strengthening.
What was IRMD's best earnings year?
IRadimed Corporation's highest annual net income on record is $22M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were IRMD's earnings last quarter?
IRMD's most recent reported quarter was Q1 2026. Net income was $6M with diluted EPS of $0.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.